According to Zoetis's latest financial reports the company has a price-to-book ratio of 15.7.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2024-12-31 | N/A | -100% |
2023-12-31 | 18.2 | 17.04% |
2022-12-31 | 15.5 | -38.95% |
2021-12-31 | 25.4 | 21.88% |
2020-12-31 | 20.8 | -10.3% |
2019-12-31 | 23.2 | 23.79% |
2018-12-31 | 18.8 | -4.48% |
2017-12-31 | 19.7 | 11.46% |
2016-12-31 | 17.6 | -19.28% |
2015-12-31 | 21.8 | 35.41% |
2014-12-31 | 16.1 | -5.04% |
2013-12-31 | 17.0 | |
2012-12-31 | N/A | |
2011-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
Pfizer PFE | 1.83 | -88.31% | ๐บ๐ธ USA |
Eli Lilly LLY | 58.0 | 270.56% | ๐บ๐ธ USA |
Sanofi SNY | 1.50 | -90.39% | ๐ซ๐ท France |
Merck MRK | 8.87 | -43.35% | ๐บ๐ธ USA |
Phibro Animal Health
PAHC | 2.73 | -82.56% | ๐บ๐ธ USA |
Heska Corporation
HSKA | 3.14 | -79.97% | ๐บ๐ธ USA |